company background image
531349 logo

Panacea Biotec BSE:531349 Stock Report

Last Price

₹421.45

Market Cap

₹25.1b

7D

11.8%

1Y

158.8%

Updated

25 Nov, 2024

Data

Company Financials

Panacea Biotec Limited

BSE:531349 Stock Report

Market Cap: ₹25.1b

531349 Stock Overview

A biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. More details

531349 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the Indian market

Significant insider selling over the past 3 months


Panacea Biotec Limited Competitors

Hester Biosciences

BSE:524669

₹20.2b

Zenotech Laboratories

BSE:532039

₹4.7b

Nirman Agri Genetics

NSEI:NIRMAN

₹2.4b

Bharat Immunologicals & Biologicals

BSE:524663

₹1.0b

Price History & Performance

Summary of all time highs, changes and price drops for Panacea Biotec
Historical stock prices
Current Share Price₹421.45
52 Week High₹420.00
52 Week Low₹112.70
Beta0.93
11 Month Change50.46%
3 Month Change72.58%
1 Year Change158.80%
33 Year Change98.56%
5 Year Change239.61%
Change since IPO1,335.95%

Recent News & Updates

Recent updates

Shareholder Returns

531349IN BiotechsIN Market
7D11.8%-0.6%0.5%
1Y158.8%44.5%27.5%

Return vs Industry: 531349 exceeded the Indian Biotechs industry which returned 44.5% over the past year.

Return vs Market: 531349 exceeded the Indian Market which returned 27.5% over the past year.

Price Volatility

Is 531349's price volatile compared to industry and market?
531349 volatility
531349 Average Weekly Movement10.6%
Biotechs Industry Average Movement6.6%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 531349's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 531349's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19841,936Rajesh Jainwww.panaceabiotec.com

Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Formulations segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as transplantation, renal disease, oncology, respiratory, pain management, diabetes and cardiovascular management, gastro-intestinal care, nephrology, osteoporosis management, orthopedics, pain management, and fever; and betacoronavirus, typhoid conjugate, pneumococcal conjugate, tetravalent dengue, hepatitis A, and varicella vaccines, etc. It also offers health supplement products; and paediatric nutrition products under the ChilRunFull, ChilRun 7+, and ChillRun No Sucrose brands.

Panacea Biotec Limited Fundamentals Summary

How do Panacea Biotec's earnings and revenue compare to its market cap?
531349 fundamental statistics
Market cap₹25.11b
Earnings (TTM)-₹147.13m
Revenue (TTM)₹5.50b

4.7x

P/S Ratio

-177.4x

P/E Ratio

Is 531349 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
531349 income statement (TTM)
Revenue₹5.50b
Cost of Revenue₹2.02b
Gross Profit₹3.48b
Other Expenses₹3.63b
Earnings-₹147.13m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-2.40
Gross Margin63.28%
Net Profit Margin-2.68%
Debt/Equity Ratio2.6%

How did 531349 perform over the long term?

See historical performance and comparison